Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RIVAROXABAN Cause Product prescribing error? 168 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 168 reports of Product prescribing error have been filed in association with RIVAROXABAN (Rivaroxaban). This represents 0.1% of all adverse event reports for RIVAROXABAN.

168
Reports of Product prescribing error with RIVAROXABAN
0.1%
of all RIVAROXABAN reports
25
Deaths
106
Hospitalizations

How Dangerous Is Product prescribing error From RIVAROXABAN?

Of the 168 reports, 25 (14.9%) resulted in death, 106 (63.1%) required hospitalization, and 17 (10.1%) were considered life-threatening.

Is Product prescribing error Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RIVAROXABAN. However, 168 reports have been filed with the FAERS database.

What Other Side Effects Does RIVAROXABAN Cause?

Gastrointestinal haemorrhage (20,041) Haemorrhage (6,571) Epistaxis (5,629) Rectal haemorrhage (4,501) Off label use (4,463) Haematuria (4,387) Upper gastrointestinal haemorrhage (4,247) Cerebrovascular accident (4,111) Anaemia (3,907) Acute kidney injury (3,735)

What Other Drugs Cause Product prescribing error?

SOMATROPIN (1,123) SACUBITRIL\VALSARTAN (1,023) SECUKINUMAB (821) TOFACITINIB (805) DUPILUMAB (725) NIRMATRELVIR\RITONAVIR (611) PREGABALIN (476) METHOTREXATE (434) TORSEMIDE (352) METOPROLOL (325)

Which RIVAROXABAN Alternatives Have Lower Product prescribing error Risk?

RIVAROXABAN vs RIVASTIGMINE RIVAROXABAN vs RIVOTRIL RIVAROXABAN vs RIZATRIPTAN RIVAROXABAN vs ROACTEMRA RIVAROXABAN vs ROCURONIUM

Related Pages

RIVAROXABAN Full Profile All Product prescribing error Reports All Drugs Causing Product prescribing error RIVAROXABAN Demographics